SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-020879
Filing Date
2023-02-14
Accepted
2023-02-14 09:02:21
Documents
15
Period of Report
2023-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm236507d1_8k.htm   iXBRL 8-K 45807
2 EXHIBIT 2.1 tm236507d1_ex2-1.htm EX-2.1 144789
3 EXHIBIT 10.1 tm236507d1_ex10-1.htm EX-10.1 129688
4 EXHIBIT 99.1 tm236507d1_ex99-1.htm EX-99.1 29704
  Complete submission text file 0001104659-23-020879.txt   607377

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sesn-20230213.xsd EX-101.SCH 3033
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sesn-20230213_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sesn-20230213_pre.xml EX-101.PRE 22595
9 EXTRACTED XBRL INSTANCE DOCUMENT tm236507d1_8k_htm.xml XML 3586
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23623212
SIC: 2834 Pharmaceutical Preparations